Patients on long-term corticosteroids may experience unpredictable appetite patterns, making it harder to gauge whether tirzepatide is working or whether steroid-driven hunger is overriding the medication's satiety effects
More than one-half of individuals with severe mental illnesses are obese or overweight, 1 resulting from multiple factors that may include psychiatric symptoms (eg, anergia and hyperphagia), poor dietary choices, sedentary lifestyle, underlying inflammatory processes, medical comorbidities, and iatrogenic consequences of certain medications
Side effects and how to manage them Both semaglutide and the ketogenic diet have well-documented side effect profiles
The honest answer: Right now, no GLP-1 medications are approved for use during pregnancy
These medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
(Interestingly enough, the provider does not need to be enrolled in Medicare, but must not be on the Preclusion List.) How does the Bridge interact with Medicares existing GLP-1 coverage